Passive transfer of tumour-derived MDSCs inhibits asthma-related airway inflammation

Scandinavian Journal of Immunology

Volumn 79, Issue 2, 2014, Pages 98-104

  Song, C ^a,b   Yuan, Y ^a   Wang, X M ^a   Li, D ^a   Zhang, G M ^a   Huang, B ^a   Feng, Z H ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b BENGBU MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CYTOKINE; IMMUNOGLOBULIN E; INTERLEUKIN 4; MONOCYTE CHEMOTACTIC PROTEIN 1; OVALBUMIN; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA1; CCL2 PROTEIN, MOUSE; GAMMA INTERFERON;

ALLERGY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BONE MARROW CELL; CANCER STEM CELL; CELL INFILTRATION; CELL THERAPY; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; LUNG; LUNG LAVAGE; LUNG PARENCHYMA; MEDIATOR; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SERUM; SUPPRESSOR CELL; TH2 CELL; TRACHEOBRONCHIAL TOILET; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL MOTION; IMMUNOLOGY; MYELOID PROGENITOR CELL; NEOPLASM; PHYSIOLOGY; TRANSPLANTATION; TUMOR CELL LINE;

ANIMALS; ASTHMA; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CCL2; INTERFERON-GAMMA; MICE; MICE, INBRED BALB C; MYELOID PROGENITOR CELLS; NEOPLASMS; TH2 CELLS;

EID: 84897019484     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12140     Document Type: Article

References (39)

1. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59:469-78.
2. Urbano FL. Review of the NAEPP 2007 Expert Panel Report (EPR-3) on asthma diagnosis and treatment guidelines. J Manag Care Pharm 2008;14:41-9.
3. Wang HY, Wong GW, Chen YZ et al. Prevalence of asthma among Chinese adolescents living in Canada and in China. CMAJ 2008;179:1133-42.
4. Hawrylowicz CM, O'Garra A. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 2005;5:271-83.
5. Papiris S, Kotanidou A, Malagari K, Roussos C. Clinical review: severe asthma. Crit Care 2002;6:30-44.
6. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009;9:162-74.
7. Nagaraj S, Gabrilovich DI. Tumor escape mechanism governed by myeloid-derived suppressor cells. Cancer Res 2008;68:2561-3.
8. + non-migratory myeloid cells suppress Th2 effector function in the lung. Mucosal Immunol 2010;3:578-93.
9. Deshane J, Zmijewski JW, Luther R et al. Free radical-producing myeloid-derived regulatory cells: potent activators and suppressors of lung inflammation and airway hyperresponsiveness. Mucosal Immunol 2011;4:503-18.
10. Solito S, Bronte V, Mandruzzato S. Antigen specificity of immune suppression by myeloid-derived suppressor cells. J Leukoc Biol 2011;90:31-6.
11. Meyer EH, DeKruyff RH, Umetsu DT. T cells and NKT cells in the pathogenesis of asthma. Annu Rev Med 2008;59:281-92.
12. Hamid Q, Tulic M. Immunobiology of asthma. Annu Rev Physiol 2009;71:489-507.
13. + myeloid cells derived from tumor-bearing mice inhibit mice inhibit primary T cell activation induced through CD3/CD28 costimulation. J Immunol 2000;165:779-85.
14. Huang B, Lei Z, Zhao J et al. CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers. Cancer Lett 2007;252:86-92.
15. Li H, Han Y, Guo Q, Zhang M, Cao X. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-β1. J Immunol 2009;182:240-9.
16. Yang L, Pang Y, Moses HL. TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol 2010;31:220-7.
17. Ilkovitch D, Lopez DM. Urokinase-mediated recruitment of myeloid-derived suppressor cells and their suppressive mechanisms are blocked by MUC1/sec. Blood 2009;113:4729-39.
18. Nagaraj S, Schrum AG, Cho HI, Celis E, Gabrilovich DI. Mechanism of T cell tolerance induced by myeloid-derived suppressor cells. J Immunol 2010;184:3106-16.
19. Qiu Z, Fujimura M, Kurashima K et al. Enhanced airway inflammation and decreased subepithelial fibrosis in interleukin 6-deficient mice following chronic exposure to aerosolized antigen. Clin Exp Allergy 2004;34:1321-8.
20. Wohlleben G, Müller J, Tatsch U et al. Influenza A virus infection inhibits the efficient recruitment of Th2 cells into the airways and the development of airway eosinophilia. J Immunol 2003;170:4601-11.
21. Ostrand-Rosenberg S. Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity. Cancer Immunol Immunother 2010;59:1593-600.
22. Rodriguez PC, Ochoa AC. Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol Rev 2008;222:180-91.
23. Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 2009;182:4499-506.
24. Bossé Y, Rola-Pleszczynski M. Controversy surrounding the increased expression of TGF β1 in asthma. Respir Res 2007;8:66.
25. Faria AM, Weiner HL. Oral tolerance and TGF-beta-producing cells. Inflamm Allergy Drug Targets 2006;5:179-90.
26. Bierie B, Moses HL. Transforming growth factor β (TGF-β) and inflammation in cancer. Cytokine Growth Factor Rev 2010;21:49-59.
27. Yoshimura A, Wakabayashi Y, Mori T. Cellular and molecular basis for the regulation of inflammation by TGF-β. J Biochem 2010;147:781-92.
28. Shull MM, Ormsby I, Kier AB et al. Targeted disruption of the mouse transforming growth factor-β 1 gene results in multifocal inflammatory disease. Nature 1992;359:693-9.
29. Christ M, McCartney-Francis NL, Kulkarni AB et al. Immune dysregulation in TGF-β1-deficient mice. J Immunol 1994;153:1936-46.
30. + myeloid cells. Cancer Res 2006;66:6807-15.
31. + immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res 2006;66:1123-31.
32. Qian BF, Wahl SM. TGF-β can leave you breathless. Curr Opin Pharmacol 2009;9:454-61.
33. Ford JG, Rennick D, Donaldson DD et al. IL-13 and IFN-γ: interactions in lung inflammation. J Immunol 2001;167:1769-77.
34. Thivierge M, Stanková J, Rola-Pleszczynski M. IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages. J Immunol 2001;167:2855-60.
35. + cells in human allergic diseases. J Allergy Clin Immunol 1997;100:1-6.
36. Broide DH, Finkelman F, Bochner BS, Rothenberg ME. Advances in mechanisms of asthma, allergy, and immunology in 2010. J Allergy Clin Immunol 2011;127:689-95.
37. Orihara K, Dil N, Anaparti V, Moqbel R. What's new in asthma pathophysiology and immunopathology? Expert Rev Respir Med 2010;4:605-29.
38. Bara I, Ozier A, Tunon de Lara JM, Marthan R, Berger P. Pathophysiology of bronchial smooth muscle remodelling in asthma. Eur Respir J 2010;36:1174-84.
39. Marigo I, Bosio E, Solito S et al. Tumor-induced tolerance and immune suppression depend on the C/EBPβ transcription factor. Immunity 2010;32:790-802.